Portopulmonary hypertension (POPH) is a serious complication of cirrhosis that is
associated with mortality beyond that predicted by the Model for End‐Stage Liver Disease …

As a result of the success of orthotopic liver transplantation, there has been increasing
interest in the diagnosis and therapeutic options for the pulmonary vascular complications of …

Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (POPH) are
pulmonary vascular complications of portal hypertension with divergent clinicopathologic …

Hepatopulmonary syndrome (HPS) is a severe complication of advanced liver disease
associated with an extremely poor prognosis. HPS is diagnosed in 4-47% of patients with …

Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are distinct
clinical entities that may complicate liver disease. Although HPS and PPHTN are different …

Portopulmonary hypertension (POPH) is an uncommon but serious pulmonary vascular
consequence of portal hypertension. Untreated, POPH results in right heart failure and …

Portopulmonary hypertension (PPHTN) and hepatopulmonary syndrome (HPS) are distinct
clinical entities that may accompany liver disease. While PPHTN and HPS have been …

Madan N, Arnon R, Arnon R. Evaluation of cardiac manifestations in pediatric liver transplant
candidates. Abstract: Knowledge concerning the involvement of the cardiovascular system …

The MetS and cardiovascular disease are leading causes of late morbidity in adult liver
transplantation recipients; however, limited data are available in pediatric liver …

• Fifthly, hepatocyte injury may be induced by accumulation of hydrophobic bile acids in
cholestatic liver diseases, 1 causing oncotic necrosis or apoptosis.• Finally, it is possible that …